United Health Products Inc (UEEC)

[Waverunners]

Most CEOs don’t like to announce that they have made their first sales in 3 years.
Especially when they previously announced that they stopped selling Hemostyp in 2018, in order to focus all their collective energy into the PMA which is no further along then it SHOULD have been 18 months ago.

Dec 2020

“As we have made clear all along, we believe that the highest value of our unique technology lies in applications within the “Class III” or human surgical market. We made the decision two years ago to devote our limited capital and manpower to securing an FDA Pre-Market Approval (“PMA”) to sell our HemoStyp cellulose product into the surgical market where the benefits to patients are most impactful and the competitive landscape much narrower.”